Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...

A report that was jointly produced by the Canadian Centre for Policy Alternatives and the Parkland Institute finds Alberta's ...

Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease and beta-thalassemia enabling accelerated access to gene therapies73% ...

The State of Trust Report by Vanta, which surveyed IT and business leaders in the U.S., U.K., and Australia in July 2025, ...